Tagged with Gilead

Andrew Hexter – Vice President & General Manager Asia 5, Gilead Sciences
Global Pharma Execs Hail ‘Unprecedented’ Speed & Collaboration of COVID-19 Response
Orphan Drugs: Building the Regulatory Framework in the Czech Republic
Pavel Brezina – Managing Director of Czech Republic & Slovakia, Gilead Sciences
US Medicare Vows to Increase Payments for Cell & Gene Therapy
Top 50 Drugs in Sweden 2018
Rogers Luo Yongqing – Global VP and General Manager (China), Gilead Sciences
Egypt’s Hep C ‘Tour n’ Cure’ – Friend or Foe?
Interview: Hilary Hutton – Squire General Manager UK & Ireland, Gilead
Top 10 Pharma Companies in Canada Ranking (2016)
Interview: Kennet Brysting – General Manager, Gilead Sciences Canada
Austria: Orchestrating Innovation
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here